Coverage
-
December 13, 2018
A Maryland federal judge has tossed claims brought by regenerative medicine company Osiris Therapeutics Inc. that its rival MiMedx Group Inc. breached a contract and stole trade secrets when the company acquired Osiris' former distributor, holding that the court lacked jurisdiction to hear the lawsuit.
1 other articles on this case.
View all »